OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/04/2025
Voltar para busca
Dado oficial do USPTO
CSL VIFOR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CSL VIFOR
ST13
US500000079376320Classe
1, 3, 5, 9, 10, 40, 41, 42, 44
Pedido
79376320
Registro
7416641
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
05/04/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 3, 5, 9, 10, 40, 41, 42, 44
Data de depósito
16/03/2023
Data de registro
18/06/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/06/2024
Última transação
05/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH
Examinador
CAYSIDO, REBECCA
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Vifor (International) AG (Vifor (International) Ltd.) (Vifor (International) Inc.)
Representantes
Scott D. Woldow Smith, Gambrell & Russell, LLP
Classificação técnica
Classes Nice
Classe 1Classe 3Classe 5Classe 9Classe 10Classe 40Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical reagents for non-medical purposes; biological reagents for scientific and research use; cell cultures for scientific and research use and cell culture media for scientific and research use; laboratory and scientific test kitstesting kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use and chemical test kits for chemical or biological analysis for laboratory or research use; chemical preparations for scientific and industrial useother than for medical or veterinary use; diagnostic agents and testing meansdiagnostic reagents and preparationsexcept for medical or veterinary use; chemical and biological reagents for non-medical scientific and research use; chemical and biological research reagents for industrial use for anti-body screeningblood groupingfor the typing and detection of specific blood cellsdetermining the presence of antigens on blood cellsthe detection of relevant complement compounds and immunoglobulin subtypesall of the foregoing for non-medical purposes; chemical test kits for the detection of specific blood cellsdetermining the presence of antigens on blood cellsthe detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research purposes; chemical preparations for industrial use for anti-body screeningblood groupingthe typing and detection of specific blood cells
Classe 3
Cleaningpolishing and abrasive preparations; degreasersother than for use in manufacturing processes
Classe 5
Pharmaceutical preparations and substances for the treatment of kidney diseasesblood conditionstransplant conditions; Pharmaceutical preparations and substances for the treatment of iron deficienciesanemianephrology; blood plasma; blood productsblood for medical purposes; products derived from bloodcord blood for medical purposes; products derived from recombinant DNA technologyhuman recombinant insulin and hormones; vaccines; colostral antibodies for medical purposes; monoclonal antibodies for medical purposes; reagent red-blood cells for medical use; test kitsdiagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; diagnostic productsmedical diagnostic reagents and diagnostic preparations for medical purposes; blood productsblood plasma; medical and veterinary test kitsdrug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; influenza vaccines; adjuvants for medical purposes and antigens being synthetic peptides for the treatment of blood disorders; pharmaceutical preparations and substances for the treatment and prevention of blood or bleeding disorders; blood productsblood plasmareagent blood cells for medical use; products derived from blood and products derived from recombinant DNA technologycolostral antibodies being immunoglobulinshuman albuminblood clotting factor preparationsplasma volume expandersblood proteins for therapeutic medical use; serums for medical usemedicated antivenom serum for treatment of venomous bites and stings; medicated serums for the treatment of blood or bleeding disorders; test kitsin-vitro diagnostic reagent test kits comprised of medical diagnostic reagents for use in detecting cell-mediated immune response for disease testing; pharmaceutical preparations and substancesmedical diagnostic rhesus factor-D reagents for the detection of specific antigens and for use in blood typing for medical use; pharmaceutical preparationsreagent red blood cells used to detect antibodies or immunoglobulin G subtypes for medical use; pharmaceutical preparationsmonoclonal and polyclonal antibodies for medical purposes; pharmaceutical preparationsreagents for medical or clinical medical use for the typing and detection of specific blood cellsthe detection of relevant complement components and immunoglobulin subtypes; pharmaceutical and veterinary preparations for use in oncology and for treating diabetes; pharmaceutical and veterinary preparations for use in transplantationtransplantation rejection therapy and transplantation-associated diseases and conditions; pharmaceutical and veterinary preparations comprising stem cells for medical or veterinary use; pharmaceutical and veterinary preparations for use in treatment and prevention of dialysis-associated diseasesconditions and complications; pharmaceutical and veterinary preparations for use in preserving and improving renal functionfor the treatment and prevention of acute kidney injuryfor the treatment and prevention of chronic kidney diseases and associated complications; pharmaceutical and veterinary preparations for the treatment and prevention of cardiaccardiovascularcirculatoryrenal systemkidneycardio-renalimmune systemgastroenterologicalgastrointestinalstomachdermatologicalhematologicalbonerespiratorygeneticallergicinflammationinfectiouspaincentral nervous systemendocrinologyhormonalmuscularrheumaticocular and metabolic diseases and disorders; pharmaceutical and veterinary preparations used as immune system stimulators for the treatment and prevention of chronic kidney diseases; pharmaceutical preparations for the treatment and prevention of mineral deficiencies and mineral overload as well as diseases and conditions associated with mineral deficiencies or mineral overload; pharmaceutical preparations for the treatment and prevention of metal deficiencies and metal overload as well as diseases and conditions associated with metal deficiencies or metal overload; pharmaceutical preparations for the treatment and prevention of vitamin deficiencies and vitamin overload as well as diseases and conditions associated with vitamin deficiencies or vitamin overloadvitamin and mineral supplementsvitamin preparations and mineral preparations for medical use
Classe 9
Downloadable software for providing medical test results; downloadable application software for providing medical test results; downloadable software applications for providing medical test results; downloadable computer software and programs for providing medical test results; electronic or recorded multimedia publicationsdownloadable electronic publications in the nature of articles and newsletters in the field of blood disorders; downloadable publications in electronic form in the nature of articles and newsletters in the field of blood disorders; electronic audiovisual teaching materialsaudiovisual recordings featuring educational healthcare information; printed publications in electronically readable or downloadable formdownloadable e-books in the field of healthcare; electronic publications downloadable from the internet or from any other communication networkdownloadable written articles in the field of medicine; educational materials in the form of computer software and programsapplications for use on mobile telephonesdownloadable educational mobile applications for accessing and reading medical news; educational materials in the form of pre-recorded media being flash drives featuring healthcare information and medical news; downloadable software that can represent goods virtuallydownloadable virtual reality software for medical teaching; downloadable digital multimedia files containing textvideosaudio recordings relating to healthcare authenticated by non-fungible tokens (NFTs)
Classe 10
Surgical apparatus and instruments; medical apparatus and instruments for monitoring blood properties and respiratory events; implantable medical devicesintravascular implants comprised of artificial material; analysis apparatus and instruments for medical usemedical diagnostic instruments for the analysis of body fluids and medical instrument for cardiovascular diagnostics; medical apparatus and instrumentsmedical apparatus and instruments for monitoring vital signsblood properties and respiratory events; medical apparatus and instruments for monitoring blood oxygen saturationblood gas concentrationsvital signs; test kitsdiagnostic kits consisting primarily of probesbuffers and reagents for use in microbial testing
Classe 40
Treatment of waste materials; treatment of biological products through biomanufacturing for otherscustom manufacturing and fractionation of blood to manufacture pharmaceuticals to the order and requirements of a customer using biological organisms in the manufacturing process; treatment and transformation of reagents and ancillary products through custom manufacture of medical reagents for immunohaematology laboratories for third parties to order; processing of human blood plasmaremoving whole blood and separating red blood cells from plasma for the custom manufacture of medicines; treatment of human blood and plasma for the custom manufacture of pharmaceuticals; fractionation of human blood and plasma for the custom manufacture of medicines; custom manufacturing of human blood and plasma to the order and requirements of a customer
Classe 41
Education servicesmedical training and teaching; health trainingtraining in the use and operation of medical imaging apparatus; consultancy services relating to training and education in the field of medical training; provision of education servicesproviding classescoursesconferencesworkshops and seminars in the field of healthcare via an online forum; provision of training and education courses in the field of healthcare; publication of educational material being booksjournals and manuals in the medical field; dissemination of printed educational material of others in the field of medicine; entertainment via weblogproviding a website featuring blogs featuring healthcare and medicine; open access publishing serviceselectronic publication of information on a wide range of topics in healthcare and medicine by publication of electronic textsjournals online and over a global computer network; entertainment servicesonline provision of non-downloadable virtual goods being toys for use in virtual environments created for entertainment purposes; providing online electronic publicationsnot downloadable in the nature of booksarticlesnewsletters in the field of medicine
Classe 42
Scientific and technological servicesscientific researchanalysistesting in the field of medicine; scientific research and development; pharmaceutical research and development; medical research and development in the field of blood disorders; blood product research and development services; clinical research in the field of medical uses of blood; provision of testing facilities for testing of pharmaceuticals; rental of research facilities for conducting scientific research in the field of medicine; laboratory analysis and research in the field of pharmaceuticals; scientific research consulting through technical planning of scientific research projects of others; technical consulting in the field of pharmaceutical studies through preparation of technical studiestechnical reportsscientific reports; medical research through conducting of scientific and medical research projects and through preparation of reports relating to scientific and medical research; provision of medical research services and facilitiesmedical research through provision of research resultsinformation and outcomes; provision of medical research information relating to all the aforementioned services; medical research consultancy services relating to all the aforementioned services; provision of medical research information relating to the aforementioned services over a global computer network; medical research laboratory services through providing scientific research studies and scientific testing of human blood plasma for safety and quality screening; medical research laboratory services regarding human blood plasma for medical diagnostics; hosting of blogs
Classe 44
Medical services; medical information services provided via the Internet; health care services; Internet-based health care information services; medical diagnostic servicesmedical testing and analysis relating to the diagnosis and treatment of disease; patient support servicesreporting of consumer authorized clinical testing results directly to the patient; medicalpharmaceutical and blood product consultancy services to provide medical consultation in the selection and use of medicalpharmaceutical and blood products; medical advisory services; providing medical information concerning pharmaceuticalsmedical products and blood products; blood bank services; health centre services through operating blood and plasma collection centres; medical testing for diagnostic or treatment purposes and medical screening services; medical testing of human blood plasma for medical diagnostic or treatment purposes; medical services for the collectionprocessing and testing of human blood and plasma; providing medical information concerning blood products; providing medical information concerning vaccinesantivenoms and immunohaematology products being diagnostic reagents; patient support servicesproviding patient medical information where patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community creation purposes via an Internet-based database
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/02/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
20/02/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/02/2025
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
05/12/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
05/12/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/09/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
18/06/2024
GPNX
NOTIFICATION PROCESSED BY IB
16/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/04/2024
PUBO
PUBLISHED FOR OPPOSITION
02/04/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/03/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/02/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
29/02/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
29/02/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
29/02/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
29/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/02/2024
RFNP
REFUSAL PROCESSED BY IB
28/11/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/11/2023
RFRR
REFUSAL PROCESSED BY MPU
07/11/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/11/2023
CNRT
NON-FINAL ACTION WRITTEN
06/11/2023
DOCK
ASSIGNED TO EXAMINER
02/11/2023
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
23/10/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
24/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
29/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/08/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
18/08/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/08/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CSL VIFOR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.